Heidelberg Pharma AG (ETR:HPHA) | WebDisclosure

Basculer en Français

9820	Companies
197077	Keywords
128165	Articles
104819	Press releases

Home
Companies
Heidelberg Pharma AG

PRESS RELEASE

published on 10/23/2025 at 07:57, 3 months 15 days ago

Heidelberg Pharma’s Lead ADC Candidate HDP-101 Granted Fast Track Designation by US FDA for the Treatment of Multiple Myeloma
Heidelberg Pharma's lead ADC candidate HDP-101 granted Fast Track Designation by US FDA for the treatment of multiple myeloma. Accelerated review for innovative cancer therapy

Heidelberg Pharma Multiple Myeloma Fast Track Designation ADC Candidate US FDA
BRIEF

published on 10/09/2025 at 07:08, 3 months 29 days ago

Bilan de l'activité pharmaceutique Heidelberg pour les neuf premiers mois de 2025

Résultats Financiers Essais Cliniques Heidelberg Pharma HDP-101 Ajustement De La Stratégie
BRIEF

published on 10/09/2025 at 07:08, 3 months 29 days ago

Heidelberg Pharma's Nine-Month Update for 2025

Financial Results Clinical Trials Heidelberg Pharma HDP-101 Strategy Adjustment
PRESS RELEASE

published on 10/09/2025 at 07:03, 3 months 29 days ago

Heidelberg Pharma Reports on the First Nine Months of Financial Year 2025
Heidelberg Pharma AG reports operational progress and financial figures for the first nine months of fiscal year 2025, focusing on lead ADC candidate HDP-101 and cost-saving measures

Financial Report Clinical Trial Cost-saving Measures Heidelberg Pharma AG ADC Candidate
BRIEF

published on 10/06/2025 at 16:03, 4 months ago

Heidelberg Pharma AG Revises Financial Guidance for 2025

Financial Guidance Heidelberg Pharma ADCs Operating Expenses Cash Requirements
BRIEF

published on 10/06/2025 at 16:03, 4 months ago

Heidelberg Pharma AG révise ses prévisions financières pour 2025

Heidelberg Pharma ADC Orientation Financière Dépenses D'exploitation Besoins De Trésorerie
PRESS RELEASE

published on 10/06/2025 at 15:58, 4 months ago

EQS-Adhoc: Heidelberg Pharma AG Announces Updated Guidance
Heidelberg Pharma AG adjusts its financial guidance for 2025, focusing on cost-saving measures. Sales, operating expenses, and cash requirements revised

Sales Financial Guidance Cost-saving Measures Heidelberg Pharma AG Operating Expenses
BRIEF

published on 09/25/2025 at 13:22, 4 months 12 days ago

Heidelberg Pharma Advances HDP-101 in Clinical Trial for Multiple Myeloma

HDP-101 Multiple Myeloma Safety Profile Phase I/IIa Trial Clinical Activity
BRIEF

published on 09/25/2025 at 13:22, 4 months 12 days ago

Heidelberg Pharma fait progresser le HDP-101 dans un essai clinique pour le myélome multiple

HDP-101 Myélome Multiple Profil De Sécurité Essai De Phase I/IIa Activité Clinique
PRESS RELEASE

published on 09/25/2025 at 13:17, 4 months 12 days ago

Heidelberg Pharma Advances to Cohort 9 in Phase I/IIa Trial of Lead ATAC Candidate HDP-101 in Multiple Myeloma
Heidelberg Pharma advances to Cohort 9 in Phase I/IIa trial of lead ATAC candidate HDP-101 in multiple myeloma, demonstrating favorable safety profile and early signs of clinical activity

Heidelberg Pharma Multiple Myeloma ATAC Candidate Phase I/IIa Trial Clinical Activity

Accesswire

Published on 02/07/2026 at 01:00, 13 hours 24 minutes ago

Green Bridge Metals Can Help Secure U.S. Production of Critical Mineral Titanium
Published on 02/06/2026 at 23:10, 15 hours 14 minutes ago

Topline Capital Management, LLC Announces Disposition of Shares of NamSys Inc.
Published on 02/06/2026 at 22:01, 16 hours 23 minutes ago

Totec Resources Announces Listing of Shares on the Frankfurt Stock Exchange and Adoption of Omnibus Incentive Plan
Published on 02/06/2026 at 15:30, 22 hours 54 minutes ago

Vulcan Minerals Inc. - Drilling Program Update for the Carbonear Zinc-Lead SEDEX project in Newfoundland
Published on 02/06/2026 at 13:30, 1 day ago

Redwood AI Corp. (formerly Marshall Technologies Corp.) Announces Closing of IPO and Listing of Shares on the Canadian Securities Exchange

View all ACCESSWIRE

EQS Group

Published on 02/06/2026 at 19:25, 18 hours 58 minutes ago

Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/06/2026 at 17:52, 20 hours 31 minutes ago

EQS-Adhoc: Avemio AG: Preparation of the filing for insolvency proceedings by Teltec AG, a subsidiary of Avemio AG, and potential effects on the going-concern assessment of Avemio AG
Published on 02/06/2026 at 17:40, 20 hours 44 minutes ago

Carvolix : Nombre d’actions composant le capital social et nombre total de droits de vote au 31.01.26.
Published on 02/06/2026 at 16:55, 21 hours 28 minutes ago

GAC MPV Serves as Official Reception Fleet for APEC China 2026, Demonstrating the Strength of Chinese Manufacturing
Published on 02/06/2026 at 15:25, 22 hours 58 minutes ago

CES 2026 Innovation Award Honoree iGarden M1 Pro Max Launches as World's First Bionic Dual-Vision Pool Cleaner

Les Echos

Published on 02/06/2026 at 18:22, 20 hours 1 minute ago

Déclaration du nombre d’actions et droits de vote au 31 janvier 2026
Published on 02/06/2026 at 18:22, 20 hours 1 minute ago

Disclosure of Share Capital and Voting Rights as of January 31, 2026
Published on 02/06/2026 at 16:01, 22 hours 22 minutes ago

Notice of exercise of early redemption option of the subordinated note ISIN : FR0010093328
Published on 02/06/2026 at 16:01, 22 hours 22 minutes ago

Exercice de l’option de remboursement de l'instrument subordonné FR0010093328
Published on 02/06/2026 at 07:54, 1 day 6 hours ago

ENGIE - Déclaration du nombre total d'actions et de droits de vote au 31 janvier 2026

View all LES ECHOS COMFI WIRE